Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34βE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung
- 1 September 2001
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 32 (9) , 918-925
- https://doi.org/10.1053/hupa.2001.27110
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Thyroid-specific enhancer-binding protein/thyroid transcription factor 1 is not required for the initial specification of the thyroid and lung primordiaBiochimie, 1999
- Neural Cell Adhesion Molecules (NCAM) and NCAM-PSA Expression in Neuroendocrine Lung TumorsThe American Journal of Surgical Pathology, 1998
- TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lungCancer Letters, 1998
- Determination of lung as the primary site of cerebral metastatic adenocarcinomas using monoclonal antibody to thyroid transcription factor-1Journal of Neuro-Oncology, 1998
- Regulation of Clara cell secretory protein gene transcription by thyroid transcription factor-1Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1997
- Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma.Journal of Clinical Pathology, 1997
- Expression of thyroid transcription factor-1(TTF-1) in fetal and neonatal human lung.Journal of Histochemistry & Cytochemistry, 1996
- The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis.Molecular and Cellular Biology, 1994
- Basal cell (basaloid) carcinoma of the lung: A new morphologic and phenotypic entity with separate prognostic significanceHuman Pathology, 1992
- Neuroendocrine Tumors of the Lung With Proposed Criteria for Large-Cell Neuroendocrine CarcinomaThe American Journal of Surgical Pathology, 1991